FindTrial
Sign In

Samudrasauvarchaladi Varti In The Management of the Nadivrana w.s.r Pilonidal Sinus

A clinical study on Samudrasauvarchaladi Varti in the management of the Nadivrana w.s.r Pilonidal Sinus - Nill

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/10/046364
Enrollment
30
Registered
2022-10-11
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L050- Pilonidal cyst and sinus with abscess

Interventions

None listed

Sponsors

Madan Mohan Malviya Government Ayurved College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with signs and symptoms Nadivrana mentioned in ayurvedic literature. 2. The length of Nadi Vrana less than 15 mm.

Exclusion criteria

Exclusion criteria: 1. History of recurrent or chronic Pilonidal sinus.�  2. The length of Nadi Vrana more than 15mm 3. Unstable� patients. 4. HIV�  5. Immune deficiency syndrome. 6. Uncontrolled diabetes mellitus. 7. Immune suppressive medications.� � � � � � � � � � � � � � � � � � � � �  8. Previous participation in trial. 9. Any malignancy

Design outcomes

Primary

MeasureTime frame
Reduction in sign and symptoms of Nadi Vrana WSR Pilonidal Sinus are includes 1. Discharge 2. Pain 3. Itching 4. TendernessTimepoint: 1 month—

Secondary

MeasureTime frame
1)Reduction in sign and symptoms of Nadi Vrana WSR Pilonidal Sinus 2)Low recurrenceTimepoint: 7 days,14 days ,21 days—

Countries

India

Contacts

Public ContactDr Mahesh Dixit

Madan Mohan Malviya Government Ayurved College

prof.maheshdixit@gmail.com9414245459

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026